Cardiac Dysfunction: Clinical Trials

2 trials for Cardiac Dysfunction, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting, 1 unknown. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Recruiting 1, Unknown 1

Follow Cardiac Dysfunction: new trials by email Literature Review of Cardiac Dysfunction trials Research Report on Cardiac Dysfunction

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction
Yangxinshi tablet, Blank control - Coronary Heart Disease, Cardiac Dysfunction
Phase 4RecruitingSPH Qingdao Growful Pharmacetical Co.,Ltd27082025-11-062025-11-25
Prevention of Myocardial Dysfunction and Injury Resulting From Salter Innominate Osteotomy by Caudal Block
ropivacaine, saline - Cardiac Dysfunction, Myocardial Injury
Phase 4UnknownSi-Qin Chen402014-04-012014-08-26

Narrower conditions

Coronary Disease (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Myocardial Ischemia (1)  ·  Vascular Diseases (1)

Interventions

Ropivacaine (1)  ·  Sodium Chloride (1)  ·  Yangxinshi (1)

Sponsors

SPH Qingdao Growful Pharmacetical Co.,Ltd (1)  ·  Si-Qin Chen (1)

Countries

China (2)

Results publications

PMID 39076617, PMID 39210710, PMID 39566404, PMID 40013746